Prestige Consumer Healthcare (NYSE:PBH) Given New $97.00 Price Target at Royal Bank of Canada

Prestige Consumer Healthcare (NYSE:PBH) had its target price lifted by equities researchers at Royal Bank of Canada from $96.00 to $97.00 in a report released on Friday,Benzinga reports. The firm currently has a “sector perform” rating on the stock. Royal Bank of Canada’s price target points to a potential upside of 14.86% from the company’s current price.

A number of other equities analysts also recently weighed in on the stock. Canaccord Genuity Group boosted their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a report on Friday, February 7th. Raymond James raised shares of Prestige Consumer Healthcare to a “moderate buy” rating in a report on Thursday, December 19th. Oppenheimer raised their price objective on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. StockNews.com raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Tuesday. Finally, Sidoti downgraded Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price target for the company. in a report on Monday, December 9th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $93.33.

Prestige Consumer Healthcare Stock Up 0.1 %

NYSE PBH traded up $0.09 during trading on Friday, hitting $84.45. The stock had a trading volume of 133,754 shares, compared to its average volume of 323,040. Prestige Consumer Healthcare has a 12 month low of $62.35 and a 12 month high of $90.04. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68. The company’s 50-day moving average price is $82.25 and its two-hundred day moving average price is $78.53. The company has a market capitalization of $4.18 billion, a PE ratio of 19.78, a P/E/G ratio of 2.69 and a beta of 0.46.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. As a group, sell-side analysts forecast that Prestige Consumer Healthcare will post 4.5 EPS for the current year.

Insider Activity at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of Prestige Consumer Healthcare stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the sale, the senior vice president now owns 17,157 shares in the company, valued at $1,544,130. The trade was a 8.91 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.60% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Prestige Consumer Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in PBH. Martingale Asset Management L P increased its stake in Prestige Consumer Healthcare by 0.4% during the 3rd quarter. Martingale Asset Management L P now owns 36,971 shares of the company’s stock worth $2,666,000 after acquiring an additional 140 shares during the period. Horizon Kinetics Asset Management LLC grew its holdings in shares of Prestige Consumer Healthcare by 4.8% during the 3rd quarter. Horizon Kinetics Asset Management LLC now owns 3,247 shares of the company’s stock worth $234,000 after purchasing an additional 150 shares in the last quarter. Franklin Resources Inc. grew its holdings in shares of Prestige Consumer Healthcare by 0.7% during the 4th quarter. Franklin Resources Inc. now owns 21,735 shares of the company’s stock worth $1,697,000 after purchasing an additional 150 shares in the last quarter. CIBC Private Wealth Group LLC increased its position in shares of Prestige Consumer Healthcare by 48.9% in the fourth quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company’s stock worth $34,000 after purchasing an additional 152 shares during the period. Finally, McIlrath & Eck LLC raised its stake in Prestige Consumer Healthcare by 19.1% in the fourth quarter. McIlrath & Eck LLC now owns 959 shares of the company’s stock valued at $75,000 after purchasing an additional 154 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors and hedge funds.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.